Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-245411
Filing Date
2025-10-21
Accepted
2025-10-21 17:43:44
Documents
1
Period of Report
2025-10-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4652
  Complete submission text file 0001193125-25-245411.txt   6095
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Hawryluk P. Kent (Reporting) CIK: 0001673991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42272 | Film No.: 251408146

Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Issuer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)